Boston ScientificBSX
About: Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Employees: 53,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
154% more first-time investments, than exits
New positions opened: 211 | Existing positions closed: 83
26% more repeat investments, than reductions
Existing positions increased: 604 | Existing positions reduced: 481
11% more funds holding in top 10
Funds holding in top 10: 35 [Q3] → 39 (+4) [Q4]
10% more capital invested
Capital invested by funds: $109B [Q3] → $120B (+$10.8B) [Q4]
8% more funds holding
Funds holding: 1,372 [Q3] → 1,479 (+107) [Q4]
2.23% more ownership
Funds ownership: 88.28% [Q3] → 90.51% (+2.23%) [Q4]
13% less call options, than puts
Call options by funds: $797M | Put options by funds: $912M
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
Needham Mike Matson 21% 1-year accuracy 26 / 121 met price target | 14%upside $113 | Buy Upgraded | 16 Apr 2025 |
Truist Securities Richard Newitter 43% 1-year accuracy 21 / 49 met price target | 14%upside $113 | Buy Maintained | 11 Apr 2025 |
Stifel Rick Wise 21% 1-year accuracy 7 / 34 met price target | 21%upside $120 | Buy Maintained | 10 Feb 2025 |
Barclays Matt Miksic 40% 1-year accuracy 16 / 40 met price target | 19%upside $118 | Overweight Maintained | 10 Feb 2025 |
UBS Danielle Antalffy 50% 1-year accuracy 6 / 12 met price target | 31%upside $130 | Buy Maintained | 7 Feb 2025 |
Financial journalist opinion
Based on 27 articles about BSX published over the past 30 days
